InveniAI Introduces New Products to its AI-Powered Pharmaceutical Drug Discovery and Development Suite GUILFORD, Conn., Nov. 06, 2019 (GLOBE NEWSWIRE) -- InveniAI® Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation...

ContraVir Pharmaceuticals to Present at BIO-Europe Spring 2017 EDISON, N.J., March 14, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral...